Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Prostate cancer and prostatic diseases"
DOI: 10.1038/s41391-021-00339-y
Abstract: BACKGROUND In patients presenting with metastatic prostate cancer, the role of local therapy is evolving. Two recently reported large-scale randomized trials suggest that radiotherapy (RT) directed at the prostate improves overall survival (OS) in patients… read more here.
Keywords: prostate; newly diagnosed; metastatic prostate; prostate cancer ... See more keywords
Survival trends in patients diagnosed with metastatic prostate cancer: A nationwide analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.6_suppl.171
Abstract: 171Background: The risk of prostate cancer (PCa)-death in men diagnosed with metastatic (M+) PCa is high. During the past decade, new life-prolonging therapies have been approved for the treatment of advanced PCa. Even though demonstrated… read more here.
Keywords: prostate; analysis; prostate cancer; survival trends ... See more keywords
PD-L1 expression and TMB status in newly diagnosed metastatic non-small cell lung cancer and their effect on prognosis after EGFR-TKI or platinum-based chemotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e24294
Abstract: e24294Background: Programmed cell death 1 ligand (PD-L1) expression and the tumour mutation burden (TMB) are distinct biomarkers of response to anti-PD-1/PD-L1 therapies. The proportion of PD-L1-positive, high-TMB patients and their overlap in newly diagnosed metastatic… read more here.
Keywords: metastatic non; newly diagnosed; expression; diagnosed metastatic ... See more keywords